GPCR薬の創生動向：新たな薬物、標的、適応
Trends in GPCR drug discovery: new agents, targets and indications p.829
doi: 10.1038/nrd.2017.178
Volume 16 Number 12
Analysis
Review Article
免疫疾患と炎症性疾患の治療法としてのJAKの阻害
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases p.843
doi: 10.1038/nrd.2017.201
タウを基盤とする神経変性疾患の治療法：機会と課題
Tau-based therapies in neurodegeneration: opportunities and challenges p.863
doi: 10.1038/nrd.2017.155
